Login
Super Investors Catalys Pacific, LLC
CP

Catalys Pacific, LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$210M
Positions
2
Quarter ended
September 30, 2026
Filed
October 30, 2026

Reported portfolio value by quarter (12 quarters reported)

$351M $107M
Q4 23 Q3 24 Q2 25 Q1 26 Q3 26

$107M in Q4 2023 → $210M now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
Mineralys Therapeutics, Inc. 93.4% Trimmed 1.3% 7,799,518 $196M
Phathom Pharmaceuticals, Inc. 6.6% Added 26% 1,882,039 $13.7M

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q3 2026

quarter ended September 30, 2026 · filed October 30, 2026

Company Action Shares changed Value of change % of portfolio
Phathom Pharmaceuticals, Inc. Added +388,185 +$2.83M 6.6%
Mineralys Therapeutics, Inc. Trimmed −104,320 −$2.62M 93.4%

Q2 2026

quarter ended June 30, 2026 · filed August 05, 2026

No position changes this quarter.

Q1 2026

quarter ended March 31, 2026 · filed May 14, 2026

Company Action Shares changed Value of change % of portfolio
Phathom Pharmaceuticals, Inc. Added +64,840 +$720K 7.2%

Q4 2025

quarter ended December 31, 2025 · filed February 10, 2026

Company Action Shares changed Value of change % of portfolio
Mineralys Therapeutics, Inc. Trimmed −1,000,000 −$36.3M 92.4%
Phathom Pharmaceuticals, Inc. Added +261,900 +$4.34M 7.6%

Q3 2025

quarter ended September 30, 2025 · filed November 14, 2025

No position changes this quarter.

Q2 2025

quarter ended June 30, 2025 · filed August 13, 2025

No position changes this quarter.

Q1 2025

quarter ended March 31, 2025 · filed August 13, 2025

Company Action Shares changed Value of change % of portfolio
Mineralys Therapeutics, Inc. Added +259,259 +$4.12M 95.1%

Q4 2024

quarter ended December 31, 2024 · filed February 14, 2025

Company Action Shares changed Value of change % of portfolio
Hillevax, Inc. Exited −236,379 −$416K —
Phathom Pharmaceuticals, Inc. Added +44,542 +$362K 8.2%

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support